MDxHealth S.A.
MDXH
Pozycja w akcjach
#21498
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Cena akcji
$3.58
Ostatnia synchronizacja: 2023-12-15
Kapitalizacja rynkowa
$101.57M
Zmiana (1 dzień)
3.79%
Zmiana (1 rok)
0.01%
Kraj
BE
Handel MDxHealth S.A. (MDXH)
Kategoria
Healthcare
Historia stopy dywidendy dla MDxHealth S.A. (MDXH)
Stopa dywidendy (TTM) dla MDxHealth S.A. (symbol akcji: MDXH) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla MDxHealth S.A. (MDXH) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| Za mało danych dla podanych dat. | ||
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 0.27% |
US
|
|
| 0.68% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
CN
|
|
| 0.59% |
US
|
